Interviews

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines some of the latest pharmacy services developed by Rite Aid.

Jay Greco, RPh, owner of Jersey Shore Pharmacy, discusses significant issues causing difficulties for specialty pharmacy.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts the ways in which pharmacy may change over the next 2-3 years.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), gives some tips for pharmacists on how to keep a quality, compliant compounding practice.

Marc O'Connor, chief operating officer of Curant Health, discusses methods Curant uses to maintain adherence to specialty drug regimens.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses how compounding laws vary from state to state.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines several successful patient counseling techniques with respect to improved medication adherence.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses how proper medication adherence habits allow patients to better manage their chronic conditions.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses the current status of provider status movements on the state level.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the growth of the annual NASP Specialty Pharmacy Conference, held from Sept. 29 through Oct. 1, 2015.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the difficulties pharmacies face regarding clinical support for patients starting specialty therapies.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses different legislative issues generating buzz on the state level, including biosimilars.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses significant challenges in over the next five years in specialty pharmacy.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses the current status of provider status movements on the state level.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how accountable care organizations impact specialty pharmacy.

David Lassen, chief clinical officer at Prime Therapeutics, discusses the potential long term impact from biosimilars on the specialty drug landscape.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about how health benefit design can increase smoking cessation.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses the standards that illustrate quality in specialty pharmacy.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses the biggest roadblocks to managing asthma.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, discusses the advantages of community pharmacy-led smoking cessation programs versus other health providers' programs.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses counseling points for different asthma medication classes.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses changes ahead for specialty pharmacy patients.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses how health care reform has changed specialty pharmacy.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses how MinuteClinic enhances COPD management.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about how to prepare community pharmacists to provide both behavioral and pharmacotherapeutic smoking cessation advice.

Doug Long, vice president of industry relations at IMS Health, talks about trends pharmacists should look out for in the future.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses metrics in care transitions that pharmacists should pay attention to.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, discusses how community pharmacies can build new networks of customers.

Doug Long, vice president of industry relations at IMS Health, talks about how the movement toward value-based care in the US health system affects community pharmacy.